loader image
Saturday, November 22, 2025
75.3 F
McAllen
- Advertisement -

Reshaping the Fight against Heart Disease

Translate to Spanish or other 102 languages!

February is American Heart Month, a time for people to pay more attention to their cardiovascular health. Image for illustration purposes
February is American Heart Month, a time for people to pay more attention to their cardiovascular health. Image for illustration purposes

Mega Doctor News

- Advertisement -

By American Physiological Society (APS)

Rockville, Md. — February is American Heart Month, a time for people to pay more attention to their cardiovascular health. The American Physiological Society (APS) member-experts studying cardiovascular disease are advancing our understanding and underscoring the critical role of cardiovascular research happening behind the scenes. Physiologists, including APS member-experts, are studying several areas such as cardiovascular disease in women, how lack of sleep affects heart health, and cardiovascular health in premature babies. The research is aimed at developing new and improved treatments, as well as eliminating or reducing some heart disease risks.

Heart disease is the leading cause of death for men and women of all racial and ethnic backgrounds in the U.S., according to the U.S. Centers for Disease Control and Prevention (CDC). More than 650,000 people in the U.S. die each year from heart disease—about 1 in every 4 deaths, the CDC reports. The most common type of heart disease in the U.S. is coronary artery disease (CAD), the precursor to a heart attack. The annual cost of heart disease to the U.S. economy as of 2017 was $363 billion.  

- Advertisement -

There are many risk factors for heart disease, according to the CDC, including:

  • • Diabetes
  • • Obesity
  • • Physical inactivity
  • • Smoking
  • • Excessive alcohol use
  • • Unhealthy diet

APS has assembled a team of leading researchers to speak with science and health journalists about their cardiovascular research:

  • Andreas M. Beyer, PhD, FAHA, FCVS-APS, associate professor of medicine and physiology, co-director of cardio-oncology, Medical College of Wisconsin. His research focuses on microvascular function in patients with CAD or in cancer patients post-chemotherapy.
  • Licy L. Yanes Cardozo, MD, associate professor, University of Mississippi Medical Center. She studies cardiovascular disease in women, among other topics.
  • Jason R. Carter, PhD, professor, Montana State University. He is studying how lack of sleep from binge drinking affects heart health. Carter is a past Councilor of APS.
  • Melissa Bates, PhD, FAPS, assistant professor, University of Iowa. She conducts cardiovascular research in premature babies. Bates is chair of the APS Respiration Section.
  • Michael Sturek, MS, PhD, professor, Indiana University School of Medicine; adjunct professor, Purdue University, West Lafayette, Indiana; chair of the APS Cardiovascular Section. He studies CAD and other subjects.
- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Current Heart Attack Screening Tools Are Not Optimal and Fail to Identify Half the People Who Are at Risk

Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at risk of having one, according to a new study led by Mount Sinai researchers.

Don’t Overfill Your Plate or Stomach

We’ve all been there: You’re gathered with family or friends for a delicious holiday meal. You start piling food on your plate, and before you know it, there’s no room left – and you haven’t even made it to the cranberry sauce and sweet potatoes.

UT Health San Antonio Center For Brain Health Celebrates with Ribbon Cutting

University of Texas System and UT San Antonio leaders today hailed “a new era of hope, healing and discovery” for neurological patients and their families with a ribbon-cutting for the UT Health San Antonio Center for Brain Health, a $100 million, 103,000-square-foot facility that will bring specialty care, therapy, diagnostics and research under one ro

Rare Mutation that Predicts Strong Immunotherapy Response in Colorectal Cancer Identified

A new study led by researchers at The University of Texas MD Anderson Cancer Center shows that a specific subset of mutations in the POLE gene is strongly associated with durable responses to immunotherapy in patients with metastatic colorectal cancer (CRC).
- Advertisement -
×